未登录
分享
收藏
分享
收藏A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel; Miranda, Pedro; Korkosz, Mariusz; Vencovsky, Jiri; Rubbert-Roth, Andrea; Mysler, Eduardo; Sleeman, Matthew A.; Godwood, Alex; Sinibaldi, Dominic; Guo, Xiang; White, Wendy I.; Wang, Bing; Wu, Chi-Yuan; Ryan, Patricia C.; Close, David; Weinblatt, Michael E.
分享
收藏Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: Relevance for human safety
Ryan, Patricia C.; Sleeman, Matthew A.; Rebelatto, Marlon; Wang, Bing; Lu, Hong; Chen, Xiaomin; Wu, Chi-Yuan; Hinrichs, Mary Jane; Roskos, Lorin; Towers, Heidi; McKeever, Kathleen; Dixit, Rakesh
分享
收藏Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors
LoRusso, Patricia; Jaenne, Pasi A.; Oliveira, Moacyr; Rizvi, Naiyer; Malburg, Lisa; Keedy, Vicki; Yee, Lorrin; Copigneaux, Catherine; Hettmann, Thore; Wu, Chi-Yuan; Ang, Agnes; Halim, Abdel-Baset; Beckman, Robert A.; Beaupre, Darrin; Berlin, Jordan
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏